000			02171 a2200673 4500
005			20250513174716.0
264		0	_c19990520
008			199905s 0 0 eng d
022			_a0022-2623
024	7		_a10.1021/jm9801307 _2doi
040			_aNLM _beng _cNLM
100	1		_aJacobsen, E J
245	0	0	_aPiperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality. _h[electronic resource]
260			_bJournal of medicinal chemistry _cApr 1999
300			_a1123-44 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAnti-Anxiety Agents _xchemical synthesis
650	0	4	_aAnticonvulsants _xchemical synthesis
650	0	4	_aAnxiety _xmetabolism
650	0	4	_aBiological Availability
650	0	4	_aCell Line
650	0	4	_aCerebellum _xdrug effects
650	0	4	_aConvulsants _xtoxicity
650	0	4	_aCyclic GMP _xantagonists & inhibitors
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aGABA Agonists _xchemical synthesis
650	0	4	_aImidazoles _xchemical synthesis
650	0	4	_aIn Vitro Techniques
650	0	4	_aLigands
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aModels, Molecular
650	0	4	_aMolecular Conformation
650	0	4	_aPentylenetetrazole _xtoxicity
650	0	4	_aPiperazines _xchemical synthesis
650	0	4	_aQuinoxalines _xchemical synthesis
650	0	4	_aRats
650	0	4	_aRats, Inbred F344
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, GABA-A _xmetabolism
650	0	4	_aSeizures _xchemically induced
650	0	4	_aStructure-Activity Relationship
650	0	4	_aUrea _xanalogs & derivatives
700	1		_aStelzer, L S
700	1		_aTenBrink, R E
700	1		_aBelonga, K L
700	1		_aCarter, D B
700	1		_aIm, H K
700	1		_aIm, W B
700	1		_aSethy, V H
700	1		_aTang, A H
700	1		_aVonVoigtlander, P F
700	1		_aPetke, J D
700	1		_aZhong, W Z
700	1		_aMickelson, J W
773	0		_tJournal of medicinal chemistry _gvol. 42 _gno. 7 _gp. 1123-44
856	4	0	_uhttps://doi.org/10.1021/jm9801307 _zAvailable from publisher's website
999			_c10157353 _d10157353